Company: XAIR
Filing Date: 2025-02-10
Form Type: 10-Q
Source: 0001493152-25-005678
Chunk: 95

Company: Beyond Air, Inc.
Filing Date: 2025-02-10
Form: 10-Q
Item: Part II, Item 8
Chunk 95
---
 securities and restricted cash 
    $11,182  
    $34,698 

     14 

BEYOND
AIR, INC. AND SUBSIDIARIES

NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

NOTE
2 SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (continued)

The
following table summarizes the Company’s short-term marketable securities with unrealized gains and losses as of December 31, 2024,
aggregated by major security type:

 SUMMARY
OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED GAINS AND LOSSES

    (in thousands) 
    Fair Value  
    Unrealized Gains 
  
    Corporate debt securities 
    $-  
    $- 
  
    U.S. government securities 
     -  
     - 
  
    Mutual fund (ultra-short-term income) 
     6,349  
     15 
  
    Total short-term marketable securities 
    $6,349  
    $15 

The
following table summarizes our short-term marketable securities with unrealized gains and losses as of March 31, 2024, aggregated by
major security type:

    (in thousands) 
    Fair Value  
    Unrealized Gains 
  
    Corporate debt securities 
    $-  
    $- 
  
    U.S. government securities 
     16,388  
     117 
  
    Mutual fund (ultra-short-term income) 
     6,702  
     6 
  
    Total short-term marketable securities 
    $23,090  
    $123 

All
marketable securities are A- or higher rated. No marketable securities have maturities greater than 12 months. All investments are level
1 investments.

Segment
Reporting

Commencing
with the creation of Beyond Cancer in November 2021, the Company’s operations became classified into two segments, Beyond Air and
Beyond Cancer. Each segment has its own management team, board of directors, corporate officers and legal entities. As of December 31,
2024, Beyond Air, Inc. owns 80% of the common stock of Beyond Cancer. The segment reporting is based on the manner in which the Company’s
CEO as chief operating decision maker assesses performance and allocates resources across the organization.